Down-regulation of human epidermal growth factor receptor 2/neu oncogene by corosolic acid induces cell cycle arrest and apoptosis in NCI-N87 human gastric cancer cells

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 6, 2010, Pages 931-937

  Lee, Myung S ^a   Cha, Eun Y ^a   Thuong, Phuong T ^b   Kim, Ji Y ^c   Ahn, Moon S ^c   Sul, Ji Young ^c  

^a Chungnam National University College of Medicine   (South Korea)

^b National Institute of Medicinal Materials   (Viet Nam)

^c Chungnam National University   (South Korea)

Author keywords

Corosolic acid; Gastric cancer; Human epidermal growth factor receptor 2 neu

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; COROSOLIC ACID; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROTEIN KINASE B; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG SYNTHESIS; ENZYME ACTIVITY; GENE CONTROL; HUMAN; HUMAN CELL; PHARMACOGENETICS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION; GENES, ERBB-2; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; POLY(ADP-RIBOSE) POLYMERASES; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRITERPENES;

EID: 77953407311     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.931     Document Type: Article

References (39)

1. Kelley J. R., Duggan J. M., J. Clin. Epidemiol., 56, 1-9 (2003).
2. Yu G. Z., Chen Y., Wang J. J., J. Cancer Res. Clin. Oncol., 135, 1331-1339 (2009).
3. Wiedmann M. W., Caca K., Curr. Cancer Drug Targets, 5, 171-193 (2005).
4. Bianco R., Melisi D., Ciardiello F., Tortora G., Eur. J. Cancer, 42, 290-294 (2006).
5. Scaltriti M., Verma C., Guzman M., Jimenez J., Parra J. L., Pedersen K., Smith D. J., Landolfi S., Ramony Cajal S., Arribas J., Baselga J., Oncogene, 28, 803-814 (2009).
6. Carpenter G., Cohen S., J. Biol. Chem., 265, 7709-7712 (1990).
7. Moasser M. M., Oncogene, 26, 6469-6487 (2007).
8. Konecny G. E., Pegram M. D., Venkatesan N., Finn R., Yang G., Rah-meh M., Untch M., Rusnak D. W., Spehar G., Mullin R. J., Keith B. R., Gilmer T. M., Berger M., Podratz K. C., Slamon D. J., Cancer Res., 66, 1630-1639 (2006).
9. Kim J. W., Kim H. P., Im S. A., Kang S., Hur H. S., Yoon Y. K., Oh D. Y., Kim J. H., Lee D. S., Kim T. Y., Bang Y. J., Cancer Lett., 272, 296-306 (2008).
10. Liby K. T., Yore M. M., Sporn M. B., Nat. Rev. Cancer, 7, 357-369 (2007).
11. Hou W., Li Y., Zhang Q., Wei X., Peng A., Chen L., Wei Y., Phytother. Res., 23, 614-618 (2009).
12. Thuong P. T., Min B. S., Jin W., Na M., Lee J., Seong R., Lee Y. M., Song K., Seong Y., Lee H. K., Bae K., Kang S. S., Biol. Pharm. Bull., 29, 830-833 (2006).
13. Fukushima M., Matsuyama F., Ueda N., Egawa K., Takemoto J., Kaji-moto Y., Yonaha N., Miura T., Kaneko T., Nishi Y., Mitsui R., Fujita Y., Yamada Y., Seino Y., Diabetes Res. Clin. Pract., 73, 174-177 (2006).
14. Miura T., Ueda N., Yamada K., Fukushima M., Ishida T., Kaneko T., Matsuyama F., Seino Y., Biol. Pharm. Bull., 29, 585-587 (2006).
15. Ahn K. S., Hahm M. S., Park E. J., Lee H. K., Kim I. H., Planta Med., 64, 468-470 (1998).
16. Xu Y., Ge R., Du J., Xin H.,Yi T.,Sheng J.,Wang Y.,Ling C., Cancer Lett.,284, 229-237 (2009).
17. Lenferink A. E., Busse D., Flanagan W. M., Yakes F. M., Arteaga C. L., Cancer Res., 61, 6583-6591 (2001).
18. Hulit J., Lee R. J., Russell R. G., Pestell R. G., Biochem. Pharmacol., 64, 827-836 (2002).
19. Yakes F. M., Chinratanalab W., Ritter C. A., King W., Seelig S., Arteaga C. L., Cancer Res., 62, 4132-4141 (2002).
20. Menendez J. A., Vellon L., Colomer R., Lupu R., Ann. Oncol., 16, 359-371 (2005).
21. Daly R. J., Growth Factors, 16, 255-263 (1999).
22. Yarden Y., Sliwkowski M. X., Nat. Rev. Mol. Cell Biol., 2, 127-137 (2001).
23. Wagner A. D., Grothe W., Haerting J., Kleber G., Grothey A., Fleig W E., J. Clin. Oncol., 24, 2903-2909 (2006).
24. Gravalos C., Jimeno A., Ann. Oncol., 19, 1523-1529 (2008).
25. Ross J. A., Kasum C. M., Annu. Rev. Nutr., 22, 19-34 (2002).
26. Hollman P. C., Katan M. B., Food Chem. Toxicol., 37, 937-942 (1999).
27. Martin R., Ibeas E., Carvalho-Tavares J., Hernández M., Ruiz-Gutierrez V, Nieto M. L., PLoS One, 4, e5975 (2009).
28. Ovesná Z., Vachálková A., Horváthová K., Neoplasma, 51, 407-414 (2004).
29. Einbond L. S., Wen-Cai Y., He K., Wu H. A., Cruz E., Roller M., Kro-nenberg F., Phytomedicine, 15, 504-511 (2008).
30. Wakimoto N., Yin D., O'Kelly J., Haritunians T., Karlan B., Said J., Xing H., Koeffler H. P., Cancer Sci., 99, 1793-1797 (2008).
31. Kim S. Y., Kim H. P., Kim Y. J., Oh D. Y., Im S. A., Lee D., Jong H. S., Kim T. Y., Bang Y. J., Int. J. Oncol., 32, 89-95 (2008).
32. Le X. F., Pruefer F., Bast R.C. Jr., Cell Cycle, 4, 87-95 (2005).
33. Yamamoto K., Fujiwara Y., Nishida T., Takiguchi S., Nakajima K., Miyata H., Yamasaki M., Mori M., Doki Y., Anticancer Res., 29, 4211-4215 (2009).
34. Kang G. H., Kim G. S., Lee H. R., Yuh Y. J., Kim S. R., Cancer Res. Treat., 40, 106-110 (2008).
35. Wagner A. D., Moehler M., Curr. Opin. Oncol., 21, 381-385 (2009).
36. Fujimoto-Ouchi K., Sekiguchi F., Tanaka Y., Cancer Chemother. Pharmacol., 49, 211-216 (2002).
37. Pegram M., Hsu S., Lewis G., Pietras R., Beryt M., Sliwkowski M., Coombs D., Baly D., Kabbinavar F., Slamon D., Oncogene, 18, 2241-2251 (1999).
38. Gong S. J., Jin C. J., Rha S. Y., Chung H. C., Cancer Lett., 214, 215-224 (2004).
39. Fornari F. A., Randolph J. K., Yalowich J. C., Ritke M. K., Gewirtz D. A., Mol. Pharmacol., 45, 649-656 (1994).